(Q43874398)

27 November 2017

title

CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro (English)

1 reference

27 November 2017

1 reference

Eagling VA

1

1 reference

27 November 2017

Wiltshire H

series ordinal

2

1 reference

27 November 2017

Whitcombe IW

series ordinal

3

1 reference

27 November 2017

Back DJ

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

32

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

1-17

1 reference

P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Selective inhibitors of cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Saquinavir soft-gel capsule formulation. A review of its use in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250110085845

10.1080/00498250110085845

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference